Tibra Equities Europe’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-525,134
Closed -$52.1M 344
2019
Q3
$52.1M Buy
525,134
+310,134
+144% +$29.5M 6.43% 2
2019
Q2
$19.9M Buy
215,000
+147,200
+217% +$14M 1.47% 13
2019
Q1
$6.4M Buy
+67,800
New +$5.93M 0.64% 30
2018
Q3
Sell
-160,698
Closed -$12.8M 267
2018
Q2
$12.8M Buy
+160,698
New +$13.3M 1.91% 12

Other funds holding CELG

Tibra Equities Europe's CELG Position: Q4 2019 in Review

Tibra Equities Europe sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 525,134 shares — an estimated $52.1M sold.

Tibra Equities Europe first reported a position in CELG in Q2 2018 and held it in 4 quarters. The position peaked at $52.1M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Tibra Equities Europe reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 525,134 Celgene Corp shares in Q4 2019, an estimated $52.1M.
  • Tibra Equities Europe first reported a position in Celgene Corp in Q2 2018 and held it in 4 quarters.
  • Tibra Equities Europe's Celgene Corp position peaked at $52.1M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Tibra Equities Europe's 13F filing for Q4 2019, filed 14 Feb 2020.